Market Digest: DoorDash Surges on Old Navy Deal While Bristol-Myers Squibb Stumbles
DoorDash shares accelerated 6% Friday after announcing a partnership with Old Navy, marking its expansion into apparel delivery. The deal helped the delivery platform recoup some of last week's losses as investors rewarded its diversification beyond restaurant logistics.
Bristol-Myers Squibb faced headwinds after terminating a clinical trial for an experimental heart drug. The pharmaceutical setback dragged shares lower amid broader market ambivalence - the Dow fell 0.7% while the Nasdaq managed a 0.1% gain.
All eyes now turn to delayed economic reports following the federal government shutdown resolution. These data points could sway the Federal Reserve's final 2025 rate decision, with markets parsing every indicator for policy clues.